U.S. federal R&D obligations edge higher, FY 2025 seen flat as agency cuts offset gains

U.S. federal R&D obligations edge higher, FY 2025 seen flat as agency cuts offset gains
Federal R&D spending outlook

Federal research and experimental development obligations rise in FY 2024, supported by higher defense spending, while the overall FY 2025 total is estimated to remain nearly unchanged. The latest figures show nominal growth of 4.4% to $194.2 billion in FY 2024, followed by a projected 0.1% dip to $194.1 billion in FY 2025.

Highlights

  • Federal agency obligations for research and experimental development rise from $186.1 billion in FY 2023 to $194.2 billion in FY 2024, then slightly decline to $194.1 billion projected for FY 2025.
  • Department of Defense R&D obligations surge 14.4% to $97.9 billion in FY 2024, while Department of Health and Human Services declines 7.1% to $48.8 billion.
  • Most major agencies project lower R&D obligations in FY 2025, but higher Department of Commerce funding and supplemental appropriations keep the total near FY 2024 levels.

Agency shifts shape the FY 2024 and FY 2025 outlook

As reported by the National Center for Science and Engineering Statistics, federal agency obligations for research and experimental development increase from $186.1 billion in FY 2023 to $194.2 billion in FY 2024, with preliminary FY 2025 data pointing to a slight decline to $194.1 billion.

Obligations refer to orders placed, contracts awarded, services received and similar transactions during a given period, regardless of when funds are appropriated or when payments are ultimately made. Adjusted for inflation, the FY 2024 total increases 1.7% from the prior year, while the FY 2025 estimate is expected to fall 2.3% from FY 2024.

The FY 2024 increase is driven largely by the Department of Defense, where R&D obligations rise 14.4% to $97.9 billion from $85.5 billion. That increase is partly offset by the Department of Health and Human Services, where obligations decline 7.1% to $48.8 billion from $52.5 billion.

Supplemental funding limits broader federal decline

Most federal agencies estimate lower R&D obligations in FY 2025, including some of the largest spenders such as the Department of Defense, the Department of Health and Human Services, the Department of Energy and the U.S. National Science Foundation.

Those declines are expected to be counterbalanced by higher R&D obligations at the Department of Commerce, keeping the federal total close to FY 2024 levels. The data indicate supplemental appropriations continue to support overall federal R&D funding even as agency-level budgets weaken.

Historical federal fiscal year figures for 1951 through 2024 are available in the Office of Management and Budget's Budget of the U.S. Government, Fiscal Year 2025 Historical Tables.

In our earlier article on FY27 appropriations activity in the House, we outlined how the Appropriations Committee accelerated its markup and hearing schedule as lawmakers advanced multiple spending bills, including Military Construction and Veterans Affairs. We also noted that hearings with agency leaders signaled priority areas such as healthcare, defense, energy, supply chains, and space programs, underscoring how near-term budget decisions can reshape agency funding trajectories.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.